drugset / Trial / NCT01250496

Study With Aminophylline to Attenuate of the Side Effects of Regadenoson

NCT01250496 ↗

Phase 4 Terminated 248 enrolled Rush University Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The routine administration of 75 mg of intravenous aminophylline following regadenoson (Lexiscan®), a commonly used medication for nuclear stress testing of the heart, can reduce the gastrointestinal (diarrhea and stomach upset) and other side effects related to regadenoson.

Timeline

Start
2010-11
Primary completion
2011-11
Completion
2011-11

Outcome

Met primary endpoint

Stopped (Enrollment): “Due to nationwide shortage of Aminophylline. Enrolled subjects did not complete study.”

paper primary endpoint of diarrhea and abdominal discomfort [11 (8.9%) vs 22 (17.7%), P = .04] PMID 22395779 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminophylline Small molecule 75 mg Intravenous

Indications

No indication recorded.